Irritable bowel syndrome
- 1 January 1999
- journal article
- Published by Springer Nature in Current Treatment Options in Gastroenterology
- Vol. 2 (1) , 13-19
- https://doi.org/10.1007/s11938-999-0013-6
Abstract
I believe there are four essential elements in the management of patients with irritable bowel syndrome (IBS): to establish a good physician-patient relationship; to educate patients about their condition; to emphasize the excellent prognosis and benign nature of the illness; and to employ therapeutic interventions centering on dietary modifications, pharmacotherapy, and behavioral strategies tailored to the individual. Initially, I establish the diagnosis, exclude organic causes, educate patients about the disease, establish realistic expectations and consistent limits, and involve patients in disease management. I find it critical to determine why the patient is seeking assistance (eg, cancer phobia, disability, interpersonal distress, or exacerbation of symptoms). Most patients can be treated by their primary care physician. However, specialty consultations may be needed to reinforce management strategies, perform additional diagnostic tests, or institute specialized treatment. Psychological co-morbidities do not cause symptoms but do affect how patients respond to them and influence health care-seeking behavior. I find that these issues are best explored over a series of visits when the physician-patient relationship has been established. It can be helpful to have patients fill out a self-administered test to identify psychological co-morbidities. I often use these tests as a basis for extended inquiries into this area, resulting in the initiation of appropriate therapies. I encourage patients to keep a 2-week diary of food intake and gastrointestinal symptoms. In this way, patients become actively involved in management of their disease, and I may be able to obtain information from the diary that will be valuable in making treatment decisions. I do not believe that diagnostic studies for food intolerances are cost-effective or particularly helpful; however, exclusion diets may be beneficial. I introduce fiber supplements gradually and monitor them for tolerance and palatability. Synthetic fiber is often better-tolerated than natural fiber, but must be individualized. In my experience, excessive fiber supplementation often is counterproductive, as abdominal cramps and bloating may worsen. Antidiarrheal agents are very effective when used correctly, preferably in divided doses. I use them in patients in anticipation of diarrhea and especially in those who fear symptoms when engaged in activities outside the home. I encourage patients to make decisions as to when and how much to use. However, almost always, a morning dose before breakfast is used (loperamide, 2 to 6 mg) and, perhaps again later in the day when symptoms of diarrhea are prominent. I prefer antispasmodics to be used intermittently in response to periods of increased abdominal pain, cramps, and urgency. For patients with daily symptoms, especially after meals, agents such as dicyclomine before meals are useful. For patients with infrequent but severe episodes of unpredictable pain, sublingual hyoscyamine often produces rapid relief and instills confidence. In general, I recommend that oral antispasmodics be used for a limited period of time rather than indefinitely, and generally for periods of time when symptoms are prominent.Keywords
This publication has 22 references indexed in Scilit:
- Review article: irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1997
- Syuptomatology, quality of life and economic features of irritable bowel syndrome—the effect of hypnotherapyAlimentary Pharmacology & Therapeutics, 1996
- Altered rectal perception is a biological marker of patients with irritable bowel syndromeGastroenterology, 1995
- Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1994
- Antidepressant therapy in 138 patients with irritable bowel syndrome: a five‐year clinical experienceAlimentary Pharmacology & Therapeutics, 1994
- “Prokinetic” Treatment of Constipation-Predominant Irritable Bowel SyndromeJournal of Clinical Gastroenterology, 1991
- Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome.Gut, 1990
- Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.Gut, 1987
- Role of loperamide and placebo in management of irritable bowel syndrome (IBS)Digestive Diseases and Sciences, 1984
- What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?Gut, 1984